CD24 and neoplasm: The counts of CD44+CD24− BCSCs (Fig. 6f) and CD44+CD24−CD44+ BCSCs (Fig. 6h) were also significantly decreased in the tumor tissues of mice treated with the miR-7 agomir and in the Ad plus Cy group (Fig. 6g–i).